Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Elpro International Acquisition Worth ₹4.79 Cr

Elpro International Limited has acquired a stake in Cohance Lifesciences Limited for ₹4.79 Crore in cash. Cohance Lifesciences is a pharmaceutical platform specializing in CDMO, APIs, and specialty chemicals. The acquisition is intended for investment purposes, allowing Elpro to gain exposure to the pharmaceutical and specialty chemicals sectors.

Key figures
Value₹4.79 Cr
Source

NSE filing, NSE: ELPROINTL. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Elpro International Ltd: key numbers

Share price
₹165.00
Market cap
₹2,796 Cr
Revenue (annual)
₹528.1 Cr
Net profit (annual)
₹87.37 Cr
P/E (TTM)
21.6×Sector 33.7×
Promoter holding
93.02%+18.02% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Elpro International Ltd

All →
16:03 IST BSE
Acquisition

Elpro International Acquisition Worth ₹186.1 Cr

Elpro International’s subsidiary acquired a 100% stake in Quest Academy Limited for ₹186.12 Crore. This acquisition expands the company’s real estate portfolio.

Value
₹186.1 Cr

Other acquisition announcements

All →